Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. miRNA Expression in Ovarian Cancer in Fresh Frozen, Formalin-fixed Paraffin-embedded and Plasma Samples

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Preoperative predictors of inguinal lymph node metastases in vulvar cancer - A nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-risk Endometrial Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Identification of Stably Expressed Reference microRNAs in Epithelial Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Filipe Correia Martins
  • Dominique-Laurent Couturier
  • Anna Paterson
  • Anthony N Karnezis
  • Christine Chow
  • Tayyebeh M Nazeran
  • Adekunle Odunsi
  • Aleksandra Gentry-Maharaj
  • Aleksandra Vrvilo
  • Alexander Hein
  • Aline Talhouk
  • Ana Osorio
  • Andreas D Hartkopf
  • Angela Brooks-Wilson
  • Anna DeFazio
  • Anna Fischer
  • Arndt Hartmann
  • Brenda Y Hernandez
  • Bryan M McCauley
  • Chloe Karpinskyj
  • Christiani B de Sousa
  • Claus Høgdall
  • Daniel G Tiezzi
  • Esther Herpel
  • Florin Andrei Taran
  • Francesmary Modugno
  • Gary Keeney
  • Gregg Nelson
  • Helen Steed
  • Honglin Song
  • Hugh Luk
  • Javier Benitez
  • Jennifer Alsop
  • Jennifer M Koziak
  • Jenny Lester
  • Joseph H Rothstein
  • Jurandyr M de Andrade
  • Lene Lundvall
  • Luis Paz-Ares
  • Luis Robles-Díaz
  • Lynne R Wilkens
  • Maria J Garcia
  • Maria P Intermaggio
  • Marie-Lyne Alcaraz
  • Mary A Brett
  • Matthias W Beckmann
  • Mercedes Jimenez-Linan
  • Michael Anglesio
  • Michael E Carney
  • Michael Schneider
  • Nadia Traficante
  • Nadja Pejovic
  • Naveena Singh
  • Nhu Le
  • Peter Sinn
  • Prafull Ghatage
  • Ramona Erber
  • Robert Edwards
  • Robert Vierkant
  • Roberta B Ness
  • Samuel Leung
  • Sandra Orsulic
  • Sara Y Brucker
  • Scott H Kaufmann
  • Sian Fereday
  • Simon Gayther
  • Stacey J Winham
  • Stefan Kommoss
  • Tanja Pejovic
  • Teri A Longacre
  • Valerie McGuire
  • Valerie Rhenius
  • Weiva Sieh
  • Yurii B Shvetsov
  • Alice S Whittemore
  • Annette Staebler
  • Beth Y Karlan
  • Cristina Rodriguez-Antona
  • David D Bowtell
  • Ellen L Goode
  • Estrid Høgdall
  • Francisco J Candido Dos Reis
  • Jacek Gronwald
  • Jenny Chang-Claude
  • Kirsten B Moysich
  • Linda E Kelemen
  • Linda S Cook
  • Marc T Goodman
  • Peter A Fasching
  • Robin Crawford
  • Suha Deen
  • Usha Menon
  • David G Huntsman
  • Martin Köbel
  • Susan J Ramus
  • Paul D P Pharoah
  • James D Brenton
Vis graf over relationer

BACKGROUND: PTEN loss is a putative driver in histotypes of ovarian cancer (high-grade serous (HGSOC), endometrioid (ENOC), clear cell (CCOC), mucinous (MOC), low-grade serous (LGSOC)). We aimed to characterise PTEN expression as a biomarker in epithelial ovarian cancer in a large population-based study.

METHODS: Tumours from 5400 patients from a multicentre observational, prospective cohort study of the Ovarian Tumour Tissue Analysis Consortium were used to evaluate associations between immunohistochemical PTEN patterns and overall survival time, age, stage, grade, residual tumour, CD8+ tumour-infiltrating lymphocytes (TIL) counts, expression of oestrogen receptor (ER), progesterone receptor (PR) and androgen receptor (AR) by means of Cox proportional hazard models and generalised Cochran-Mantel-Haenszel tests.

RESULTS: Downregulation of cytoplasmic PTEN expression was most frequent in ENOC (most frequently in younger patients; p value = 0.0001) and CCOC and was associated with longer overall survival in HGSOC (hazard ratio: 0.78, 95% CI: 0.65-0.94, p value = 0.022). PTEN expression was associated with ER, PR and AR expression (p values: 0.0008, 0.062 and 0.0002, respectively) in HGSOC and with lower CD8 counts in CCOC (p value < 0.0001). Heterogeneous expression of PTEN was more prevalent in advanced HGSOC (p value = 0.019) and associated with higher CD8 counts (p value = 0.0016).

CONCLUSIONS: PTEN loss is a frequent driver in ovarian carcinoma associating distinctly with expression of hormonal receptors and CD8+ TIL counts in HGSOC and CCOC histotypes.

OriginalsprogEngelsk
TidsskriftBritish Journal of Cancer
Vol/bind123
Udgave nummer5
Sider (fra-til)793-802
Antal sider10
ISSN0007-0920
DOI
StatusUdgivet - sep. 2020

ID: 61424686